A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: a randomized controlled trial
Background Patients taking adjuvant endocrine therapy (AET) after breast cancer face
adherence challenges and symptom‐related distress. We conducted a randomized trial to …
adherence challenges and symptom‐related distress. We conducted a randomized trial to …
Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled …
ME Ream, EA Walsh, JM Jacobs, C Taub… - Breast cancer research …, 2021 - Springer
Purpose Despite life-saving potential, many women struggle to adhere to adjuvant
endocrine therapy (AET) for their breast cancer (BCa). Prior research has demonstrated that …
endocrine therapy (AET) for their breast cancer (BCa). Prior research has demonstrated that …
Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial
Purpose Adjuvant endocrine therapy (AET) reduces breast cancer morbidity and mortality;
however, adherence is suboptimal. Interventions exist, yet few have improved adherence …
however, adherence is suboptimal. Interventions exist, yet few have improved adherence …
CircINTS4 facilitates chemoresistance of TNBC by competitively binding miR‐129‐5p/POM121 axis
Q Tang, F Zhou, C Yang, J Dai, J Li, Y He - Journal of Oncology, 2022 - Wiley Online Library
Objectives. To detect the expression of circular RNA (circRNA) circINTS4 in triple‐negative
breast cancer (TNBC) and to analyze the relationship between the expression of circRNA …
breast cancer (TNBC) and to analyze the relationship between the expression of circRNA …
Outcomes and experiences of an online Balance-Space music therapy intervention for cancer patients: A mixed methods study
TC Rabinowitch, A Dassa, AS Sadot… - The Arts in Psychotherapy, 2023 - Elsevier
Coping with cancer requires both physical and emotional fortitude, and various intervention
programs attempt to address these needs. Since the outbreak of the COVID-19 pandemic …
programs attempt to address these needs. Since the outbreak of the COVID-19 pandemic …
Concurrent factors associated with adherence to adjuvant endocrine therapy among women with non-metastatic breast cancer
Purpose Adjuvant endocrine therapy (AET) reduces breast cancer morbidity and mortality,
yet women often report suboptimal adherence. Though correlates of AET adherence are …
yet women often report suboptimal adherence. Though correlates of AET adherence are …
[HTML][HTML] Patient-reported outcomes from phase III neoadjuvant systemic trial comparing neoadjuvant chemotherapy with neoadjuvant endocrine therapy in pre …
S Gwark, SH Ahn, WC Noh, ES Lee, Y Jung… - Frontiers in …, 2021 - frontiersin.org
We aimed to evaluate the patient-reported outcomes (PROs) in a prospective phase III
clinical trial, comparing neoadjuvant endocrine therapy (NET) with conventional …
clinical trial, comparing neoadjuvant endocrine therapy (NET) with conventional …
[PDF][PDF] A Multi-Method Investigation of Factors Associated with Adherence to/Persistence with Adjuvant Endocrine Therapy in Breast Cancer Survivors to Inform …
KI Toivonen - 2021 - prism.ucalgary.ca
Introduction: Adjuvant endocrine therapy (AET) reduces risk of hormone receptor-positive
breast cancer recurrence; however, adherence to AET is suboptimal and prior attempts to …
breast cancer recurrence; however, adherence to AET is suboptimal and prior attempts to …